“Hypothesis and Evidence: Immune CellTherapy Might Yield Poor Outcomes in Patients with Diabetes”, Adv. Life Sci. Adoles., vol. 1, no. 1, May 2025, doi: 10.64135/advadolesc.2025.01.05.